ロード中...
Prevention of ER-Negative Breast Cancer
The successful demonstration that the selective estrogen receptor modulators (SERMs) tamoxifen and raloxifene reduce the risk of breast cancer has stimulated great interest in using drugs to prevent breast cancer in high-risk women. In addition, recent results from breast cancer treatment trials sug...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4068124/ https://ncbi.nlm.nih.gov/pubmed/19213564 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|